Second-year surveillance of recipients of a respiratory syncytial virus (RSV) F protein subunit vaccine, PFP-1: evaluation of antibody persistence and possible disease enhancement

Clicks: 464
ID: 118196
1994
Free PDF
Article Quality & Performance Metrics
Overall Quality Improving Quality
0.0 /100
Combines engagement data with AI-assessed academic quality
AI Quality Assessment
Not analyzed
Abstract
In a previous study, children 18 to 36 months of age and seropositive for respiratory syncytial virus (RSV) were vaccinated with an RSV subunit vaccine (PFP-1) consisting of the viral fusion protein. Vaccines developed substantial increases in anti-fusion and neutralizing antibody and exhibited prot …
Reference Key
da1994vaccinesecond-year Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Tristram DA;Welliver RC;Hogerman DA;Hildreth SW;Paradiso P;;
Journal Vaccine
Year 1994
DOI
DOI not found
URL
http://www.ncbi.nlm.nih.gov/pubmed/8036830
Keywords
National Center for Biotechnology Information NCBI NLM MEDLINE humans pubmed abstract nih national institutes of health national library of medicine research support non-u.s. gov't female male Child Infant preschool Clinical Trial Antibodies Double-Blind Method r c welliver respiratory syncytial virus infections / prevention & control* time factors hn protein* viral envelope proteins human / immunology* human / isolation & purification respiratory syncytial virus viral / blood* viral proteins / immunology* viral vaccines / immunology* immunoglobulin e / blood pmid:8036830 doi:10.1016/0264-410x(94)90316-6 d a tristram p paradiso immunoglobulin a / blood

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.